MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
Decoy Therapeutics Inc. (DCOY)
Decoy Therapeutics Inc. (DCOY)
source: myfinsight.com
Download
Download image
Net decrease in cash
-$2,889,329
Equity-based compensation
$213,044
Depreciation and
amortization
$5,924
Net cash used in
operating activities
-$2,889,329
Canceled cashflow
$218,968
Net loss
-$2,224,628
Accrued expenses and
other
-$617,292
Prepaid expenses and
other current assets
$261,821
Accounts payable
-$4,556
Back